The H2020-funded PERMIT project aims to develop recommendations for robust and reproduciblepersonalised medicine (PM) research. One of the PERMIT working groups aimed to establish standards for the design of randomised trials in PM through the involvement of multiple stakeholders, including researchers, medicines agencies and health technology assessment bodies.
The group has developed recommendations on innovative trial designs for PM, including umbrella, basket, platform, and trials within cohort. These recommendations cover issues linked to taxonomy, methodology, statistical analysis, and more.
The goal of this training event is to analyse the main designs of randomised trials applied to PM and discuss their strengths and weakness in the context of the PERMIT recommendations.
Register at: https://forms.gle/wGDKFXALb75pZt6c6
